Edwards Lifesciences EW Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $6.07B+11.5% | $5.44B+8.6% | $5.01B+12.2% | $4.46B-14.7% | ||
| $1.33B+19.4% | $1.12B+2.7% | $1.09B— | —— | ||
| $4.73B+9.5% | $4.32B+10.2% | $3.92B+4.9% | $3.74B-6.1% | ||
| 78%-1.4pp | 79.5%+1.2pp | 78.3%-5.5pp | 83.8%+7.7pp | ||
| $1.08B+2.5% | $1.05B+6.4% | $989.8M+17.3% | $843.6M-6.6% | ||
| $2.09B+16.5% | $1.79B+8.8% | $1.65B+21.2% | $1.36B-9.1% | ||
| $67.2M+22,300% | $300K— | —— | $0— | ||
| $1.26B-8.3% | $1.38B+1.0% | $1.36B-8.9% | $1.5B-11.4% | ||
| 20.8%-4.5pp | 25.3%-1.9pp | 27.2%-6.3pp | 33.6%+1.3pp | ||
| —— | $120.3M+79.0% | $67.2M+89.3% | $35.5M+104% | ||
| $1.27B-17.8% | $1.55B+8.4% | $1.43B-6.0% | $1.52B-10.7% | ||
| $216.9M+42.6% | $152.1M-8.3% | $165.8M-15.2% | $195.5M-1.7% | ||
| $1.07B-74.3% | $4.17B+198% | $1.4B-7.9% | $1.52B+1.3% | ||
| 17.7%-59.1pp | 76.7%+48.8pp | 28%-6.1pp | 34.1%+5.4pp | ||
| $13.4M-99.5% | $2.77B+1,446% | $179.4M-9.3% | $197.9M— | ||
| $1.83-73.7% | $6.97+203% | $2.30-5.7% | $2.44+2.1% | ||
| $1.84-73.6% | $6.98+202% | $2.31-5.7% | $2.45+1.2% | ||
| 2.3B-2.4% | 2.4B-1.4% | 2.4B-2.6% | 2.5B-0.8% | ||
| 2.3B-2.3% | 2.4B-1.2% | 2.4B-2.2% | 2.5B-0.4% | ||
| $1.81-22.6% | $2.34+16.4% | $2.01-6.1% | $2.14— | ||
| $1.80-23.1% | $2.34+17.0% | $2.00-5.7% | $2.12— | ||
| $0.03-99.4% | $4.63+1,443% | $0.30-6.3% | $0.32— | ||
| $325.4M+705% | $40.4M-80.1% | $203.5M+1,188% | $15.8M-23.3% | ||
| $7.2M-89.6% | $68.9M+382% | $14.3M+198% | $4.8M-62.2% | ||
| $67.2M+22,300% | $300K— | —— | $0— | ||
| $19.1M-68.7% | $61M— | $0— | —— | ||
| —— | —— | $0-100% | $60.7M— | ||
| $6.07B+11.5% | $5.44B+8.6% | $5.01B+12.2% | $4.46B-14.7% | ||
| $1.42B-7.4% | $1.53B+1.6% | $1.51B-7.8% | $1.64B-10.3% | ||
| 23.4%-4.8pp | 28.2%-1.9pp | 30.1%-6.6pp | 36.7%+1.8pp | ||
| $1.26B-8.3% | $1.38B+1.0% | $1.36B-8.9% | $1.5B-11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Edwards Lifesciences's revenue?
- Edwards Lifesciences (EW) generated $6.3B in revenue over the trailing twelve months, up 14.1% year over year.
- Is Edwards Lifesciences profitable?
- Edwards Lifesciences reported $1.1B in net income over the trailing twelve months, a 17.4% net margin.
- What are Edwards Lifesciences's profit margins?
- Gross margin is 77.9% and operating margin is 21.4%, with a 17.4% net margin.
- What is Edwards Lifesciences's earnings per share?
- Edwards Lifesciences's diluted EPS over the trailing twelve months is $1.88.
- Where does Edwards Lifesciences's income statement data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
